Correlation Analysis of Peripheral Blood Lymphocyte Count Monocyte Count Lymphocyte to Monocyte Ratio and Clinical Data and Prognosis of Patients with Multiple Myeloma
MENG Sha, ZHANG Yang, YUE Xi, et al
West China Hospital, Sichuan University, Sichuan Chengdu 610041, China
Abstract：Objective: To explore the correlations among peripheral blood absolute lymphocyte count (ALC), absolute monocyte count (AMC), lymphocyte to monocyte ratio (LMR) and clinical data and prognosis in patients with multiple myeloma (MM). Methods: A total of 115 patients with newly diagnosed MM who were treated in the hospital from March 2016 to August 2019 were selected as the research subjects. Data such as ALC, AMC and LMR were collected, and the overall survival (OS) was statistically analyzed. Results: ① The peripheral blood ALC of the 115 patients with MM was (0.22~13.48)×109L-1, with an average of (1.77±0.45)×109L-1. The peripheral blood AMC was (0.01~0.98)×109L-1, with an average of (0.45±0.12) ×109L-1, and LMR was 1.18~12.74, with an average of 4.74±0.85. ② With median values of peripheral blood ALC, AMC and LMR as cut-off values, the patients were grouped. Differences between high ALC group and low ALC group, high AMC group and low AMC group in terms of hemoglobin (Hb), lactate dehydrogenase (LDH), β2-microspheres (β2-MG) were statistically significant (P<0.05). Differences in Hb and β2-MG between high LMR group and low LMR group were statistically significant (P<0.05). ③ Kaplan-Meier survival curves showed that the overall OS of high ALC group, low AMC group and high LMR group was significantly longer than that of low ALC group, high AMC group, and low LMR group (P<0.05). ④ Cox multivariate analysis showed that DS stage III, LDH>245U/L, Hb≤110g/L, ALC≤0.65×109L-1 and LMR≤3.85 were independent risk factors for poor prognosis of patients with initial treatment of MM (P<0.05). Conclusion: ALC, AMC and LMR of patients with MM are related to the clinical data and prognosis. Clinically, the results can be used to initially evaluate and predict the prognosis and guide clinical treatment.
蒙沙, 张杨, 岳溪, 李健. 多发性骨髓瘤患者外周血淋巴细胞计数单核细胞计数淋巴细胞与单核细胞比值与患者预后的关系[J]. 河北医学, 2021, 27(1): 56-60.
MENG Sha, ZHANG Yang, YUE Xi, et al. Correlation Analysis of Peripheral Blood Lymphocyte Count Monocyte Count Lymphocyte to Monocyte Ratio and Clinical Data and Prognosis of Patients with Multiple Myeloma. HeBei Med, 2021, 27(1): 56-60.
[1] Paner A,Patel P,Dhakal B . The evolving role of translocation t(11;14) in the biology,prognosis,and management of multiple myeloma[J]. Blood Rev,2019,7(10):100643. [2] 贾韬,朱华渊,王莉,等.外周血淋巴细胞/单核细胞比值及2个疗程后PET评价在成人霍奇金淋巴瘤中的预后意义[J].中华血液学杂志,2019,40(5):372~377. [3] Wyrwicz L,Temnyk M,Rybski S,et al. Lymphocyte-to-monocyte ratio (LMR) compared to sidedness of primary tumor to predict outcome of anti-EGFR monotherapy in metastatic colorectal cancer[J].Clin Oncol,2018,36(4):809~809. [4] 中国医师协会血液科医师分会,中华医学会血液学分会,中国医师协会多发性骨髓瘤专业委员会.中国多发性骨髓瘤诊治指南(2015年修订)[J].中华内科杂志,2015,54(12):1066~1070. [5] Taniguchi K,Karin M . NF-κB,inflammation,immunity and cancer:coming of age[J]. Nat Rev Immunol,2018,8(9):774~779.. [6] 杜德晓,韩子良,阿民布和,等.术前淋巴细胞与单核细胞比值预测胃癌淋巴结转移的价值[J].中华普通外科杂志,2020,35(4):277~280. [7] Lee K H,Kim E Y,Yun J S,et al. The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer.[J]. Bmc Cancer,2018,8(12):369~372. [8] 井瑶瑶,杨洪亮,赵海丰,等.外周血细胞计数及其比值对初诊伴非骨相关髓外病变的多发性骨髓瘤患者预后的评估价值[J].肿瘤防治研究,2019,46(5):456~462. [9] 李涵,王雪,李东英,等.外周血淋巴细胞和单核细胞计数及其比值对初治多发性骨髓瘤患者预后的预测价值[J].肿瘤,2019,37(8):865~872. [10] 唐柳,陈晓敏,黄纯兰.多发性骨髓瘤患者化疗后发生医院感染的危险因素分析[J].解放军医学院学报,2019,5(12):1127~1132.
2021, Vol. 27 
冀公网安备13080202000677号